No article text was recorded for this version.
therapeutic window constraints (stage-dependent therapeutic efficacy)
Version 2 of 2155 papers214 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application
- Blog: Tim-3 pathway dysregulation and targeting in sepsis-induced immunosuppression
- Blog: The role of IL-6 in coronavirus, especially in COVID-19
- Blog: The role of death domain proteins in host response upon SARS-CoV-2 infection: modulation of programmed cell death and translational applications
- Blog: The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis
- Blog: Preventive but Not Therapeutic Topical Application of Local Anesthetics Can Inhibit Experimental Epidermolysis Bullosa Acquisita in Mice
- Blog: Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration
- Blog: The protective association between statins use and adverse outcomes among COVID-19 patients: a systematic review and meta-analysis
- Blog: A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease
- Blog: Tenofovir alafenamide fumarate attenuates bleomycin-induced pulmonary fibrosis by upregulating the NS5ATP9 and TGF-β1/Smad3 signaling pathway
- Blog: Guideline for the diagnosis and treatment of incomplete Kawasaki disease in children in China
- Blog: A humanized mouse model of chronic COVID-19 to evaluate disease mechanisms and treatment options
- Blog: The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated With Convalescent Plasma
- Blog: Tocilizumab and COVID-19: Timing of Administration and Efficacy
- Blog: Effectiveness of Convalescent Plasma for Treatment of COVID-19 Patients
- Blog: The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated with Convalescent Plasma
- Blog: Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cells
- Blog: Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Pneumonia
- Blog: Prospects for applying the chronic social conflict model in medical and biological research
- Blog: KDS2010, a Newly Developed Reversible MAO-B Inhibitor, as an Effective Therapeutic Candidate for Parkinson's Disease
- Blog: Chemokine treatment in growth plate fracture: a pivotal role of CCL9
- Blog: The role of inflammasomes in vascular cognitive impairment
- Blog: Efficacy and safety of local glucocorticoids for the treatment of acute radiation-induced intestinal injury: protocol of a multicenter randomized controlled trial
- Blog: Effectiveness of Vaccines and Antiviral Drugs in Preventing Severe and Fatal COVID-19, Hong Kong
- Blog: NSAID use and clinical outcomes in COVID-19 patients: a 38-center retrospective cohort study
- Blog: Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands
- Blog: Severe Community-Acquired Pneumonia with Disseminated Infection Caused by Highly Virulent Pseudomonas aeruginosa: Successful Treatment of a Case
- Blog: Multipotent adult progenitor cells prevent functional impairment and improve development in inflammation driven detriment of preterm ovine lungs
- Blog: Innate immunity has a dual effect on vascular healing: Suppression and aggravation of neointimal formation and remodeling post-endotoxin challenge
- Blog: Convalescent or standard plasma versus standard of care in the treatment of COVID-19 patients with respiratory impairment: short and long-term effects. A three-arm randomized controlled clinical trial
- Blog: Colchicine use in patients with COVID-19: a systematic review and meta-analysis
- Blog: Blocking the TRAIL-DR5 Pathway Reduces Cardiac Ischemia–Reperfusion Injury by Decreasing Neutrophil Infiltration and Neutrophil Extracellular Traps Formation
- Blog: Protective effect of Secukinumab on severe sepsis model rats by neutralizing IL-17A to inhibit IKBα/NFκB inflammatory signal pathway
- Blog: Antiviral drugs arbidol and interferon alpha-1b contribute to reducing the severity of COVID-19 patients: a retrospective cohort study
- Blog: Colchicine use in patients with COVID-19: A systematic review and meta-analysis
- Blog: Cdh5-mediated Fpn1 deletion exerts neuroprotective effects during the acute phase and inhibitory effects during the recovery phase of ischemic stroke
- Blog: Bifurcated monocyte states are predictive of mortality in severe COVID-19
- Blog: The Role of Glutamate Receptors in Ischemic Stroke
- Blog: Reconstructing the temporal progression of HIV-1 immune response pathways
- Blog: Histone modifications and their roles in macrophage-mediated inflammation: a new target for diabetic wound healing
- Blog: The use of CytoSorb hemoadsorption in critically ill patients: a narrative review
- Blog: Visualization of HSP70-regulated mild-photothermal therapy for synergistic tumor treatment: a precise space-time mild-temperature photothermal ablation strategy
- Blog: TGF-β2 levels in the aqueous humor are elevated in the second eye of high myopia within two weeks after sequential cataract surgery
- Blog: Effect, safety, timing and dose of thoracic radiotherapy plus third-generation EGFR-TKIs as first-line treatment in patients with EGFR-mutated oligo-organ metastatic NSCLC
- Blog: Sepsis-induced immunosuppression: mechanisms, biomarkers and immunotherapy
- Blog: X-box Binding Protein 1: An Adaptor in the Pathogenesis of Atherosclerosis
- Blog: Blocking IL-33 decelerates cartilage degeneration in knee osteoarthritis through mice model
- Blog: Immune enhancement to prevent infected pancreatic necrosis: A double-blind randomized controlled trial
- Blog: Dexamethasone does not ameliorate gliosis in a mouse model of neurodegenerative disease
- Blog: Agrobacterium tumefaciens-mediated Transformation of Jatropha curcas: Factors Affecting Transient Transformation Efficiency and Morphology Analysis of Transgenic Calli
- Blog: Early disseminated Lyme disease
- Blog: Intravitreal Conbercept For Branch Retinal Vein Occlusion induced Macular Edema: One Initial Injection Versus Three Monthly Injections
- Blog: Disentangling the distal association between β-Amyloid and tau pathology at varying stages of tau deposition
- Blog: Comparative efficacy of different repetitive transcranial magnetic stimulation protocols for lower extremity motor function in stroke patients: a network meta-analysis
- Blog: REMEDI: REinforcement learning-driven adaptive MEtabolism modeling of primary sclerosing cholangitis DIsease progression
- Blog: Modeling drug response using network-based personalized treatment prediction (NetPTP) with applications to inflammatory bowel disease
- Blog: Trimetazidine as an adjunct to standard hydration reduces the incidence of contrast-induced acute kidney injury in patients with renal insufficiency undergoing coronary angiography or percutaneous cardiac intervention: a systematic review and meta-analysis.
- Blog: Neuroimaging biomarkers define neurophysiological subtypes with distinct trajectories in schizophrenia
- Blog: Harnessing cytokine-induced killer cells to accelerate diabetic wound healing: an approach to regulating post-traumatic inflammation
- Blog: Hematopoietic stem cell transplantation in children with acute leukemia: similar outcomes in recipients of umbilical cord blood versus marrow or peripheral blood stem cells from related or unrelated donors
Showing 60 of 155 papers.
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_therapeutic_window_constraints_stage_dep_0458d25d,
title = {therapeutic window constraints (stage-dependent therapeutic efficacy)},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/therapeutic-window-constraints-stage-dependent-therapeutic-efficacy/rdr_0458d25da15e4b5dac967cd24082cbe6},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}This exact version (version 2, frozen text):
@misc{lacuna_therapeutic_window_constraints_stage_dep_0458d25d_v2,
title = {therapeutic window constraints (stage-dependent therapeutic efficacy)},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/therapeutic-window-constraints-stage-dependent-therapeutic-efficacy/rdr_0458d25da15e4b5dac967cd24082cbe6/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-20},
}